Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

279
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
279
Obesity01:24

Obesity

1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

302
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
302
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

208
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
208
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K
Prevalence and Incidence01:08

Prevalence and Incidence

2.0K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dietary Supplement Use: United States, August 2021-August 2023.

NCHS data brief·2026
Same author

No Significant Change in Childhood Obesity.

Pediatrics·2026
Same author

Checkpoint kinase 2 coordinates autophagy activation and Aurora kinase A degradation to regulate primary cilia for cell invasion.

Cell communication and signaling : CCS·2026
Same author

Population-Level Changes in Folate, Iodine, and Vitamin D Status over More than 20 Years: Biomarker Data from the Cross-Sectional National Health and Nutrition Examination Survey (NHANES 1999-2000 through August 2021-August 2023).

Current developments in nutrition·2026
Same author

Centers for Disease Control and Prevention's 2026 Nutrition Report Presents Data for 131 Biomarkers from the Cross-Sectional National Health and Nutrition Examination Survey (NHANES 1999-August 2023).

Current developments in nutrition·2026
Same author

Indium (III) chloride inhibits testicular Leydig cell proliferation by disrupting centrosome copy numbers.

Molecular medicine reports·2026

Related Experiment Video

Updated: Feb 20, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

27.9K

Obesity Prevalence Among U.S. Adults With and Without Disabilities.

Cheryl D Fryar1, Julie D Weeks2, Catharine A Couch1

  • 1Division of Health and Nutrition Examination Surveys, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Maryland, USA.

Obesity (Silver Spring, Md.)
|February 18, 2026
PubMed
Summary

Adults with disabilities have higher obesity prevalence than those without, even after accounting for various factors. This highlights a significant public health concern for disability populations.

Keywords:
NHANESdisabilityobesity

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K
A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.5K

Related Experiment Videos

Last Updated: Feb 20, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

27.9K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K
A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.5K

Area of Science:

  • Public Health
  • Epidemiology
  • Disability Studies

Background:

  • Obesity is a major public health issue with significant health implications.
  • Understanding the prevalence of obesity across different population subgroups, including those with disabilities, is crucial for targeted interventions.

Purpose of the Study:

  • To provide current, nationally representative prevalence estimates of obesity among U.S. adults with and without disabilities.
  • To examine the association between obesity and disability status in the adult population.

Main Methods:

  • Utilized data from 5917 adults (aged ≥20 years) from the National Health and Nutrition Examination Survey (August 2021-August 2023).
  • Defined obesity using measured Body Mass Index (BMI) ≥30. Defined disability based on self-reported functional difficulties.
  • Employed logistic regression models, adjusting for sociodemographic, behavioral, and health status variables, to assess the obesity-disability association.

Main Results:

  • Overall, 40.3% of adults had obesity, and 16.5% reported disabilities.
  • Adults with disabilities exhibited a higher age-adjusted obesity prevalence (50.6%) compared to those without (37.9%).
  • Even after adjusting for multiple factors, obesity remained significantly more prevalent in adults with disabilities (adjusted prevalence ratio = 1.14).

Conclusions:

  • The observed higher obesity prevalence in adults with disabilities is not explained by differences in age, sex, race-Hispanic origin, education, smoking, or health status.
  • Findings underscore a persistent disparity in obesity rates, emphasizing the need for tailored public health strategies for individuals with disabilities.